Log in to save to my catalogue

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4922696

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

About this item

Full title

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2016-07, Vol.126 (7), p.2610-2620

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Small-cell lung cancer (SCLC) is a highly aggressive subtype of lung cancer with limited treatment options. CD47 is a cell-surface molecule that promotes immune evasion by engaging signal-regulatory protein alpha (SIRPα), which serves as an inhibitory receptor on macrophages. Here, we found that CD47 is highly expressed on the surface of human SCLC...

Alternative Titles

Full title

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4922696

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4922696

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI81603

How to access this item